SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-018159
Filing Date
2024-01-29
Accepted
2024-01-29 16:28:54
Documents
15
Period of Report
2024-01-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d687029d8k.htm   iXBRL 8-K 26221
2 EX-3.1 d687029dex31.htm EX-3.1 5866
  Complete submission text file 0001193125-24-018159.txt   160267

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA harp-20240126.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20240126_lab.xml EX-101.LAB 18724
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20240126_pre.xml EX-101.PRE 11709
16 EXTRACTED XBRL INSTANCE DOCUMENT d687029d8k_htm.xml XML 3855
Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 24574080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)